Model Number ADVIA CHEMISTRY HEMOGLOBIN A1C_3 REAGENT |
Device Problem
Device Ingredient or Reagent Problem (2910)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 08/11/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
A siemens field service engineer (fse) visited the customer site and did not find any instrument related issues, the cause of the imprecision on the patient sample for the hemoglobin a1c_3 assay is unknown.Siemens is investigating this issue.
|
|
Event Description
|
The customer is observing imprecision on patient samples for the hemoglobin a1c_3 assay on the advia chemistry 1800 instrument when using reagent lot 231.The initial and the repeat results on the patient sample did not match.As per laboratory protocol all samples >8%, that are not repeatable are sent to a reference lab for confirmation.It is unknown if patient sample results were reported to the physician(s).There were no reports of adverse health consequences due to the imprecision for hemoglobin a1c_3.
|
|
Manufacturer Narrative
|
Initial mdr 2432235-2015-00384 was filed on 9/4/2015.Follow up report mdr 2432235-2015-00384_s1 was filed on 9/25/2015.Additional information (9/30/2015): the correction/removal report (crr) was provided to the fda on 9/30/2015.
|
|
Manufacturer Narrative
|
Initial mdr 2432235-2015-00384 was filed on 9/4/2015.Additional information (9/22/2015): siemens healthcare diagnostics has confirmed the hemoglobin a1c_3/ a1c_3m reagent kit lots 230 (smn10379673 and 10485591) and 231(smn 1048559) used on the advia® 1200, 1650, 1800, 2400, and xpt chemistry systems may demonstrate an increased occurrence of high %hba1c bias.Siemens internal investigation demonstrates reagent lots 230 and 231 may exhibit a positive bias averaging 0.6% hba1c units, ranging from -0.1% to 1.1% hba1c units.The bias was observed when comparing %hba1c means to ngsp pooled patient target-value assigned samples ranging from approximately 5.5% to 8.0% hba1c.The maximum bias was observed at higher %hba1c concentrations.Qc samples may exhibit a similar bias.An urgent medical device correction (umdc) chc-15-19 is being sent to us customers and a urgent field safety notice (ufsn) chc-15-19 is being sent to ous customers in september of 2015.The umdc and ufsn state that customers are to discontinue use and discard reagent kit lots 230 and 231.
|
|
Search Alerts/Recalls
|